Eurofins Discovery
Discovery & Beyond – “The Feedback Loop” Episode 4: AI in Drug Discovery
12:27
Eurofins Discovery
Inside Analysis & Purification Chemistry Laboratory | Eurofins Discovery
1:14
Eurofins Discovery
Discovery & Beyond – “The Feedback Loop” Episode 3: Generative Chemistry Meets Automation
14:00
Eurofins Discovery
Inside Scale-Up Chemistry Laboratory | Eurofins Discovery
1:32
Eurofins Discovery
Discovery & Beyond – “The Feedback Loop” Episode 2: From Big Data to Smart Data
5:28
Eurofins Discovery
Discovery & Beyond: “The Feedback Loop” Teaser
1:36
Eurofins Discovery
Discovery & Beyond – “The Feedback Loop” Episode 1: Foundations of AI in Drug Discovery
12:08
Eurofins Discovery
Enabling Binder and Molecular Glue Discovery with High-Throughput Spectral Shift Technology
34:13
Eurofins Discovery
The potential of NAMs: fulfilling critical unmet drug discovery needs
1:17:57
Eurofins Discovery
Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities
1:01:02
Eurofins Discovery
Innovating Obesity Drug Discovery: Trends, Challenges, and Translational Strategies
53:01
Eurofins Discovery
Early De-Risking: In Vitro Safety Strategies for Pre-IND Success
48:22
Eurofins Discovery
From Discovery to Cure: Addressing the Challenges of Oncology Drug Discovery
1:03:33
Eurofins Discovery
Advancing ADC Development: End-to-End Solutions from Design to Characterisation
40:32
Eurofins Discovery
Eurofins Discovery: Bringing Decades of HTS Experience
5:53
Eurofins Discovery
Eurofins Discovery: Virtual Screening
2:11
Eurofins Discovery
Eurofins Discovery: EMERALD, a revolution in AI-powered drug discovery
2:10
Eurofins Discovery
Eurofins Discovery: SAFIRE AI Models
2:17
Eurofins Discovery
Unprecedented Fragment-Based screening using Spectral Shift for GPCRs
50:42
Eurofins Discovery
New Advances in Synthetic Chemistry to Accelerate Drug Discovery
44:48
Eurofins Discovery
Rapid Functional Cell-Based Activity Profiling of Multi-receptor Targeted Anti-obesity Therapies
39:47
Eurofins Discovery
CRISPR™ MDCKII Cell Lines Development for Bioavailability and DDI Assessments
52:03
Eurofins Discovery
SAFIRE: AI Predicted ADME for Drug Discovery: Leveraging BioPrint
44:11
Eurofins Discovery
Critical Importance of Early Safety Screening in Drug Development
43:40
Eurofins Discovery
Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterization
39:11
Eurofins Discovery
Recent Trends in Kinase Drug Discovery
17:46
Eurofins Discovery
SH2 Domains as a Target Class in Cancer and Inflammation
30:13
Eurofins Discovery
Pharmacology Discovery Services - Capabilities Video
2:58
Eurofins Discovery
Comprehensive Identification of Cardiovascular Safety Liabilities Using a Totality of Evidence
58:32
Eurofins Discovery
Accelerating hit finding programs: Echo MS and RapidFire-MS key advantages
32:26
Eurofins Discovery
Identify & Characterize New, Potent & Selective Ligands with E3scan Ligand-Binding Assay Technology
2:44
Eurofins Discovery
Successful Hit Finding for PIM3 Kinase Inhibitors: From HTS to Extended Hit Characterization
30:32
Eurofins Discovery
Versatile Hit-Finding Strategies for Successful Drug Discovery Programs
53:24
Eurofins Discovery
Eurofins Discovery Lowers Barriers to Innovation in Research & Development Through Collaboration
2:48
Eurofins Discovery
Predicting Human Toxicities: A BioMAP® Platform Narrated Case Study
3:20
Eurofins Discovery
Find your Next Novel Kinase Inhibitor with the KINOMEscan Technology
2:03
Eurofins Discovery
Decoding Cancer and Inflammation: Identifying Selective Inhibitors of SH2 Domains
28:04
Eurofins Discovery
Comprehensive In Vitro Approach to Evaluating Transporter-mediated Drug Interactions
1:00:55
Eurofins Discovery
Leveraging the E3scan technology platform for next-generation targeted protein degradation
24:20
Eurofins Discovery
Drug Discovery Trends & New Insights from Phenotypic Approaches
1:02:55
Eurofins Discovery
Eurofins Discovery IDD Highlights
0:43
Eurofins Discovery
An efficient and effective PIM3 kinase
37:11
Eurofins Discovery
In vitro NASH Panels and in vivo NASH models for NASH drug discovery
9:27
Eurofins Discovery
Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)
22:37
Eurofins Discovery
Eurofins Discovery Safety Pharmacology Portfolio
40:17
Eurofins Discovery
Eurofins Discovery: The Essence of our Entrepreneurial Spirit
2:00
Eurofins Discovery
Eurofins Discovery: We Know What It Takes
2:01
Eurofins Discovery
Eurofins Discovery: Big Enough to Deliver, Small Enough to Care
2:15
Eurofins Discovery
Eurofins Discovery: It All Starts with Biology
2:02
Eurofins Discovery
Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 2
42:06
Eurofins Discovery
Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 1
40:13
Eurofins Discovery
Oncology Drug Discovery & Early Lifestyle Solutions
18:27
Eurofins Discovery
Get More Out of BioMAP®️ Early Screening Data with Tableau
4:48
Eurofins Discovery
Global Anticancer Drug Discovery & Development Trends
52:45
Eurofins Discovery
Nerve Injury Induced Neuropathic Pain Models in Rodents – Quick Video
10:35
Eurofins Discovery
Hit Discovery for GPCRs: HTS or virtual screens?
48:32
Eurofins Discovery
Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan Technology Platform
45:51
Eurofins Discovery
HTS and Cell-Based Phenotypic Screening to Identify Potential Cardiac and Cardiovascular Liabilities
28:56
Eurofins Discovery
Eurofins Discovery | JSPS 2021 (Japanese Version) - 第12回日本安全性薬理研究会学術年会スポンサーセッション
23:04
Eurofins Discovery
Eurofins Discovery | 2021 Japan Society for the Promotion of Science - 第12回日本安全性薬理研究会学術年会スポンサーセッション
21:02
Eurofins Discovery
Small Molecule Inhibitors of Oncogenic SHP2 Variants Characterized by Cellular Target Engagement
1:04:04
Eurofins Discovery
Eurofins Discovery Case Study: Understanding TPD Complexity using BioMAP® Human Phenotypic Platform
25:02
Eurofins Discovery
Eurofins Discovery - Drug Metabolism & Safety Services
1:04
Eurofins Discovery
Challenges of Incorporating Non-Animal Preclinical Data into Drug Regulatory Applications
59:45
Eurofins Discovery
High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocyte
50:56
Eurofins Discovery
Challenges of Implementing Innovation in Drug Discovery and Development
59:41
Eurofins Discovery
Using the BioMAP® Phenotypic Platform to Pivot and Reposition
8:48
Eurofins Discovery
Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation
37:35
Eurofins Discovery
Eurofins Discovery BioMAP Services Overview
17:06
Eurofins Discovery
BioAsia Taiwan 2020
7:23
Eurofins Discovery
Phenotypic Services Center of Excellence
18:16
Eurofins Discovery
Pharmacology Discovery Services Taiwan Facility Grand Opening Ceremony
0:39
Eurofins Discovery
Validation of HTP assays using human iPSC-derived cardiomyocytes to assess cardiotoxic compounds
21:40
Eurofins Discovery
Reducing Attrition due to Drug-induced Liver Injury (DILI) Early in Drug Discovery
28:12
Eurofins Discovery
Eurofins Discovery Biomarker Services
23:07
Eurofins Discovery
Eurofins Discovery Oncopanel
22:58
Eurofins Discovery
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury Early in Drug Discovery
52:54
Eurofins Discovery
Reporter Assays for Therapeutics Targeting Signaling Pathways
27:49
Eurofins Discovery
Online Ordering of MIC Assays - Pharmacology Discovery Services
2:00
![Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initative [2020 JSPS Seminar]](/vi/1T9QzHCqvCo/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLDYpBiuaCFy06Q5p6wG7U4kiSqKIA)
Eurofins Discovery
Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initative [2020 JSPS Seminar]
36:18
Eurofins Discovery
Toxicity Signature Analysis - Translational Insights with the Speed and Ease of in vitro Evaluation
31:18
Eurofins Discovery
Eurofins Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initiative
47:54
Eurofins Discovery
The Mast Cell Receptor MrgX2 and Drug-Induced Anaphylaxis. Eurofins Discovery - Drug Target Review
1:00:50
Eurofins Discovery
Implementing ADDC Assays in QC
45:23
Eurofins Discovery
Eurofins Webinar: Preclinical Secondary Pharmacology Is an Essential Part of Drug Discovery
50:30
Eurofins Discovery
Establishing Qualified Bioassays for Checkpoint Receptors to Implement in QC Lot Release
38:20
Eurofins Discovery
Eurofins Discovery: Chemical Probes in Disease Modeling Approaches
40:12
Eurofins Discovery
Eurofins Integrated Drug Discovery Webinar
55:18
Eurofins Discovery
Eurofins Pharma Discovery Services
46:32
Eurofins Discovery
Recent Advances in Transporter Testing Strategies...
43:04
Eurofins Discovery
Eurofins Cerep-Panlabs: Epigenetic Webinar
57:42
Eurofins Discovery
Eurofins Cerep-Panlabs: Toxicity Webinar
53:09
Eurofins Discovery
Eurofins Cerep-Panlabs: Oncology Webinar
58:54
Eurofins Discovery
Eurofins Cerep-Panlabs: ADME-Tox Profiling in Drug Discovery
50:26
Eurofins Discovery
Eurofins Panlabs Safety Screening Webinar
52:12
Eurofins Discovery
Eurofins Panlabs Anti-Infective Webinar 2013
1:00:13
Eurofins Discovery
Eurofins Panlabs CNS Webinar
1:03:09
Eurofins Discovery
Eurofins Panlabs Oncology Webinar 2013
55:20